(Q34397099)
Statements
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial (English)
Philippe Hantraye
Stéphane Palfi
Jean Marc Gurruchaga
G Scott Ralph
Helene Lepetit
Sonia Lavisse
Philip C Buttery
Colin Watts
James Miskin
Michelle Kelleher
Sarah Deeley
Hirokazu Iwamuro
Jean Pascal Lefaucheur
Gilles Fenelon
Cherry Lucas
Pierre Brugières
Inanna Gabriel
Kou Abhay
Naoki Tani
Aurelie Kas
Patrice Dolphin
David P Breen
Sarah Mason
Natalie Valle Guzman
Nicholas D Mazarakis
Pippa A Radcliffe
Richard Harrop
Susan M Kingsman
Stuart Naylor
Pierre Cesaro
Kyriacos A Mitrophanous